WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination

Jie Zhang,Yuanyuan Yu,Xiuqun Zou,Yaning Du,Qiankun Liang,Mengyao Gong,Yurong He,Junqi Luo,Dandan Wu,Xiaoli Jiang,Matt Sinclair,Emad Tajkhorshid,Hong-Zhuan Chen,Zhaoyuan Hou,Yuejuan Zheng,Lin-Feng Chen,Xiao-Dong Yang

DOI: https://doi.org/10.1093/nar/gkae161

IF: 14.9

2024-03-08

Nucleic Acids Research

Abstract:Proteasome-mediated degradation of chromatin-bound NF-κB is critical in terminating the transcription of pro-inflammatory genes and can be triggered by Set9-mediated lysine methylation of the RelA subunit. However, the E3 ligase targeting methylated RelA remains unknown. Here, we find that two structurally similar substrate-recognizing components of Cullin-RING E3 ligases, WSB1 and WSB2, can recognize chromatin-bound methylated RelA for polyubiquitination and proteasomal degradation. We showed that WSB1/2 negatively regulated a subset of NF-κB target genes via associating with chromatin where they targeted methylated RelA for ubiquitination, facilitating the termination of NF-κB-dependent transcription. WSB1/2 specifically interacted with methylated lysines (K) 314 and 315 of RelA via their N-terminal WD-40 repeat (WDR) domains, thereby promoting ubiquitination of RelA. Computational modeling further revealed that a conserved aspartic acid (D) at position 158 within the WDR domain of WSB2 coordinates K314/K315 of RelA, with a higher affinity when either of the lysines is methylated. Mutation of D158 abolished WSB2's ability to bind to and promote ubiquitination of methylated RelA. Together, our study identifies a novel function and the underlying mechanism for WSB1/2 in degrading chromatin-bound methylated RelA and preventing sustained NF-κB activation, providing potential new targets for therapeutic intervention of NF-κB-mediated inflammatory diseases.

biochemistry & molecular biology

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper mainly explores the termination mechanism of the NF - κB signaling pathway in the inflammatory response. Specifically, the researchers attempt to solve the following key problems: 1. **Termination of NF - κB - dependent transcription**: - How is NF - κB bound to chromatin, especially the activation state of its RelA subunit, terminated through ubiquitination and proteasome degradation? - Is this termination mechanism independent of the existence of IκB? 2. **The role of methylation modification**: - How does monomethylation of RelA at K314/K315 sites mediated by methyltransferase Set9 affect the ubiquitination and degradation of RelA? - Is this methylation modification a key factor in triggering RelA ubiquitination? 3. **Recognition by E3 ubiquitin ligases**: - Which E3 ubiquitin ligases can recognize and target methylated RelA for ubiquitination and degradation? - What are the specific roles of WSB1 and WSB2 in this process? ### Main findings 1. **Set9 - mediated methylation**: - The study found that monomethylation of RelA at K314/K315 sites mediated by Set9 is a key step in triggering RelA ubiquitination and degradation. This process helps to terminate NF - κB - dependent gene transcription. 2. **The roles of WSB1 and WSB2**: - WSB1 and WSB2, as substrate recognition components of the Cullin - RING E3 ubiquitin ligase complex, can specifically recognize methylated RelA and promote its ubiquitination and proteasome degradation. - WSB1 and WSB2 interact with the K314/K315 sites of RelA through their N - terminal WD - 40 repeat domains (WDR), thereby promoting K48 - linked ubiquitination of RelA. 3. **Experimental verification**: - Through techniques such as cell fractionation experiments, immunoprecipitation, immunoblotting, and RNA interference, the researchers have confirmed the roles of WSB1 and WSB2 in RelA ubiquitination and degradation. - Computer modeling further revealed the important role of the conserved aspartic acid (D158) in the WDR domain of WSB2 in binding methylated RelA. ### Conclusion This study reveals new functions and mechanisms of WSB1 and WSB2 in terminating NF - κB - dependent transcription by ubiquitinating and degrading methylated RelA through proteasomes. These findings provide potential new targets for the development of therapeutic interventions for NF - κB - mediated inflammatory diseases.

WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination

UBE2G1 governs the destruction of cereblon neomorphic substrates.

UBE2G1 Governs the Destruction of Cereblon Neomorphic Substrates

Methylated DNMT1 and E2F1 Are Targeted for Proteolysis by L3MBTL3 and CRL4DCAF5 Ubiquitin Ligase

USP38 Couples Histone Ubiquitination and Methylation Via KDM5B to Resolve Inflammation

The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits

SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases

Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells.

Disruption of WSB2-mediated NOXA Degradation Induces Synthetic Lethality to Anti-apoptotic BCL-2 Family Protein Inhibitors

USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms

Wwp2 targets SRG3, a scaffold protein of the SWI/SNF-like BAF complex, for ubiquitination and degradation.

β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H

The assembly of mammalian SWI/SNF chromatin remodeling complexes is regulated by lysine-methylation dependent proteolysis

SUMOylation of the polycomb group protein L3MBTL2 facilitates repression of its target genes

The CECR2 bromodomain displays distinct binding modes to select for acetylated histone proteins versus non-histone ligands.

PDLIM2 is a novel E5 ubiquitin ligase enhancer that stabilizes ROC1 and recruits the ROC1-SCF ubiquitin ligase to ubiquitinate and degrade NF-κB RelA

Reversible Ubiquitination Shapes NLRC5 Function and Modulates NF-κB Activation Switch

Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription

SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes.

hnRNPA2B1 deacetylation by SIRT6 restrains local transcription and safeguards genome stability

Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4DCAF5 ubiquitin ligase